281 related articles for article (PubMed ID: 25378432)
1. Amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice.
Na SY; Mracsko E; Liesz A; Hünig T; Veltkamp R
Stroke; 2015 Jan; 46(1):212-20. PubMed ID: 25378432
[TBL] [Abstract][Full Text] [Related]
2. Superagonistic CD28 Protects against Renal Ischemic Injury by Expansion of Regulatory T-Cell.
Liang Y; Li Y; Kuang Q; Ding X; Wei Z; Fang Y
Am J Nephrol; 2017; 45(5):389-399. PubMed ID: 28355607
[TBL] [Abstract][Full Text] [Related]
3. CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke.
Schuhmann MK; Kraft P; Stoll G; Lorenz K; Meuth SG; Wiendl H; Nieswandt B; Sparwasser T; Beyersdorf N; Kerkau T; Kleinschnitz C
J Cereb Blood Flow Metab; 2015 Jan; 35(1):6-10. PubMed ID: 25315859
[TBL] [Abstract][Full Text] [Related]
4. Cancer Exacerbates Ischemic Brain Injury Via Nrp1 (Neuropilin 1)-Mediated Accumulation of Regulatory T Cells Within the Tumor.
Wang L; Zhou Y; Yin J; Gan Y; Wang X; Wen D; Thomson AW; Hu X; Yang L; Stetler RA; Li P; Yu W
Stroke; 2018 Nov; 49(11):2733-2742. PubMed ID: 30355201
[TBL] [Abstract][Full Text] [Related]
5. [Effect of all-trans retinoic acid on cerebral ischemia injury and regulatory T cell accounts in stroke mice].
Yang Y; Wang S; Jia W; Dong H; Wang C
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2014 May; 30(5):458-61. PubMed ID: 24796737
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin Modulates Regulatory T Cells and Attenuates Cerebral Damage in a Model of Transient Middle Cerebral Artery Occlusion in Rats.
Rodríguez-Perea AL; Gutierrez-Vargas J; Cardona-Gómez GP; Guarin CJ; Rojas M; Hernández PA
J Neuroimmune Pharmacol; 2017 Mar; 12(1):152-162. PubMed ID: 27614888
[TBL] [Abstract][Full Text] [Related]
7. Response to letter regarding article, "amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice".
Veltkamp R; Na SY; Liesz A
Stroke; 2015 Feb; 46(2):e52. PubMed ID: 25586832
[No Abstract] [Full Text] [Related]
8. Cocaine-and amphetamine-regulated transcript modulates peripheral immunity and protects against brain injury in experimental stroke.
Chang L; Chen Y; Li J; Liu Z; Wang Z; Chen J; Cao W; Xu Y
Brain Behav Immun; 2011 Feb; 25(2):260-9. PubMed ID: 20869431
[TBL] [Abstract][Full Text] [Related]
9. Letter by Gauberti and Vivien regarding article, "amplification of regulatory T cells using a CD28 superagonist reduces brain damage after ischemic stroke in mice".
Gauberti M; Vivien D
Stroke; 2015 Feb; 46(2):e50-1. PubMed ID: 25586834
[No Abstract] [Full Text] [Related]
10. Blocking of α4 integrin does not protect from acute ischemic stroke in mice.
Langhauser F; Kraft P; Göb E; Leinweber J; Schuhmann MK; Lorenz K; Gelderblom M; Bittner S; Meuth SG; Wiendl H; Magnus T; Kleinschnitz C
Stroke; 2014 Jun; 45(6):1799-806. PubMed ID: 24743435
[TBL] [Abstract][Full Text] [Related]
11.
Zhang H; Xia Y; Ye Q; Yu F; Zhu W; Li P; Wei Z; Yang Y; Shi Y; Thomson AW; Chen J; Hu X
J Neurosci; 2018 Nov; 38(47):10168-10179. PubMed ID: 30291203
[TBL] [Abstract][Full Text] [Related]
12. Resveratrol Pretreatment Protected against Cerebral Ischemia/Reperfusion Injury in Rats via Expansion of T Regulatory Cells.
Yang H; Zhang A; Zhang Y; Ma S; Wang C
J Stroke Cerebrovasc Dis; 2016 Aug; 25(8):1914-21. PubMed ID: 27184615
[TBL] [Abstract][Full Text] [Related]
13. Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson's disease mice.
Badr M; McFleder RL; Wu J; Knorr S; Koprich JB; Hünig T; Brotchie JM; Volkmann J; Lutz MB; Ip CW
J Neuroinflammation; 2022 Dec; 19(1):319. PubMed ID: 36587195
[TBL] [Abstract][Full Text] [Related]
14. Rapid regulatory T-cell response prevents cytokine storm in CD28 superagonist treated mice.
Gogishvili T; Langenhorst D; Lühder F; Elias F; Elflein K; Dennehy KM; Gold R; Hünig T
PLoS One; 2009; 4(2):e4643. PubMed ID: 19247496
[TBL] [Abstract][Full Text] [Related]
15. Essential role of program death 1-ligand 1 in regulatory T-cell-afforded protection against blood-brain barrier damage after stroke.
Li P; Mao L; Liu X; Gan Y; Zheng J; Thomson AW; Gao Y; Chen J; Hu X
Stroke; 2014 Mar; 45(3):857-64. PubMed ID: 24496394
[TBL] [Abstract][Full Text] [Related]
16. In vivo activation of Treg cells with a CD28 superagonist prevents and ameliorates chronic destructive arthritis in mice.
Win SJ; Kühl AA; Sparwasser T; Hünig T; Kamradt T
Eur J Immunol; 2016 May; 46(5):1193-202. PubMed ID: 26711629
[TBL] [Abstract][Full Text] [Related]
17. PD-L1 Monoclonal Antibody Treats Ischemic Stroke by Controlling Central Nervous System Inflammation.
Bodhankar S; Chen Y; Lapato A; Dotson AL; Wang J; Vandenbark AA; Saugstad JA; Offner H
Stroke; 2015 Oct; 46(10):2926-34. PubMed ID: 26306753
[TBL] [Abstract][Full Text] [Related]
18. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages.
Offner H; Subramanian S; Parker SM; Wang C; Afentoulis ME; Lewis A; Vandenbark AA; Hurn PD
J Immunol; 2006 Jun; 176(11):6523-31. PubMed ID: 16709809
[TBL] [Abstract][Full Text] [Related]
19. Recombinant T-cell receptor ligand RTL1000 limits inflammation and decreases infarct size after experimental ischemic stroke in middle-aged mice.
Zhu W; Dotson AL; Libal NL; Lapato AS; Bodhankar S; Offner H; Alkayed NJ
Neuroscience; 2015 Mar; 288():112-9. PubMed ID: 25556831
[TBL] [Abstract][Full Text] [Related]
20. Regulatory T cells modulate postischemic neovascularization.
Zouggari Y; Ait-Oufella H; Waeckel L; Vilar J; Loinard C; Cochain C; Récalde A; Duriez M; Levy BI; Lutgens E; Mallat Z; Silvestre JS
Circulation; 2009 Oct; 120(14):1415-25. PubMed ID: 19770391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
